HomeComparePEYE vs EQR

PEYE vs EQR: Dividend Comparison 2026

PEYE yields 102.56% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEYE wins by $4.28M in total portfolio value
10 years
PEYE
PEYE
● Live price
102.56%
Share price
$1.95
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.32M
Annual income
$1,481,817.76
Full PEYE calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — PEYE vs EQR

📍 PEYE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEYEEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEYE + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PEYE pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEYE
Annual income on $10K today (after 15% tax)
$8,717.95/yr
After 10yr DRIP, annual income (after tax)
$1,259,545.10/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, PEYE beats the other by $1,256,298.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEYE + EQR for your $10,000?

PEYE: 50%EQR: 50%
100% EQR50/50100% PEYE
Portfolio after 10yr
$2.18M
Annual income
$742,818.68/yr
Blended yield
34.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

PEYE
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEYE buys
0
EQR buys
0
No recent congressional trades found for PEYE or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEYEEQR
Forward yield102.56%4.73%
Annual dividend / share$2.00$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$4.32M$40.5K
Annual income after 10y$1,481,817.76$3,819.61
Total dividends collected$3.87M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PEYE vs EQR ($10,000, DRIP)

YearPEYE PortfolioPEYE Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$20,956$10,256.41$11,248$547.57+$9.7KPEYE
2$42,511$20,087.62$12,701$666.53+$29.8KPEYE
3$83,570$38,082.81$14,405$814.59+$69.2KPEYE
4$159,386$69,966.82$16,413$999.84+$143.0KPEYE
5$295,256$124,712.82$18,795$1,232.92+$276.5KPEYE
6$531,835$215,911.30$21,639$1,527.95+$510.2KPEYE
7$932,535$363,471.12$25,057$1,903.80+$907.5KPEYE
8$1,593,439$595,626.55$29,197$2,385.87+$1.56MPEYE
9$2,656,155$951,175.34$34,250$3,008.70+$2.62MPEYE
10$4,323,904$1,481,817.76$40,467$3,819.61+$4.28MPEYE

PEYE vs EQR: Complete Analysis 2026

PEYEStock

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Full PEYE Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this PEYE vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEYE vs SCHDPEYE vs JEPIPEYE vs OPEYE vs KOPEYE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.